Persistent Legionnaires’ Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms

ABSTRACT Despite the importance of pneumonia to public health, little is known about the composition of the lung microbiome during infectious diseases, such as pneumonia, and how it evolves during antibiotic therapy. To study the possible relation of the pulmonary microbiome to the severity and outc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ana Elena Pérez-Cobas, Christophe Ginevra, Christophe Rusniok, Sophie Jarraud, Carmen Buchrieser
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://doaj.org/article/30bfe028c1d3403082067cc267659c3d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:30bfe028c1d3403082067cc267659c3d
record_format dspace
spelling oai:doaj.org-article:30bfe028c1d3403082067cc267659c3d2021-11-15T15:56:46ZPersistent Legionnaires’ Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms10.1128/mBio.00889-202150-7511https://doaj.org/article/30bfe028c1d3403082067cc267659c3d2020-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00889-20https://doaj.org/toc/2150-7511ABSTRACT Despite the importance of pneumonia to public health, little is known about the composition of the lung microbiome during infectious diseases, such as pneumonia, and how it evolves during antibiotic therapy. To study the possible relation of the pulmonary microbiome to the severity and outcome of this respiratory disease, we analyzed the dynamics of the pathogen and the human lung microbiome during persistent infections caused by the bacterium Legionella pneumophila and their evolution during antimicrobial treatment. We collected 10 bronchoalveolar lavage fluid samples from three patients during long-term hospitalization due to pneumonia and performed a unique longitudinal study of the interkingdom microbiome, analyzing the samples for presence of bacteria, archaea, fungi, and protozoa by high-throughput Illumina sequencing of marker genes. The lung microbiome of the patients was characterized by a strong predominance of the pathogen, a low diversity of the bacterial fraction, and an increased presence of opportunistic microorganisms. The fungal fraction was more stable than the bacterial fraction. During long-term treatment, no genomic changes or antibiotic resistance-associated mutations that could explain the persistent infection occurred, according to whole-genome sequencing analyses of the pathogen. After antibiotic treatment, the microbiome did not recover rapidly but was mainly constituted of antibiotic-resistant species and enriched in bacteria, archaea, fungi, or protozoa associated with pathogenicity. The lung microbiome seems to contribute to nonresolving Legionella pneumonia, as it is strongly disturbed during infection and enriched in opportunistic and/or antibiotic-resistant bacteria and microorganisms, including fungi, archaea, and protozoa that are often associated with infections. IMPORTANCE The composition and dynamics of the lung microbiome during pneumonia are not known, although the lung microbiome might influence the severity and outcome of this infectious disease, similar to what was shown for the microbiome at other body sites. Here we report the findings of a comprehensive analysis of the lung microbiome composition of three patients with long-term pneumonia due to L. pneumophila and its evolution during antibiotic treatment. This work adds to our understanding of how the microbiome changes during disease and antibiotic treatment and points to microorganisms and their interactions that might be beneficial. In addition to bacteria and fungi, our analyses included archaea and eukaryotes (protozoa), showing that both are present in the pulmonary microbiota and that they might also play a role in the response to the microbiome disturbance.Ana Elena Pérez-CobasChristophe GinevraChristophe RusniokSophie JarraudCarmen BuchrieserAmerican Society for MicrobiologyarticleLegionella pneumophilaantibiotic resistancepneumoniapulmonary microbiomeMicrobiologyQR1-502ENmBio, Vol 11, Iss 3 (2020)
institution DOAJ
collection DOAJ
language EN
topic Legionella pneumophila
antibiotic resistance
pneumonia
pulmonary microbiome
Microbiology
QR1-502
spellingShingle Legionella pneumophila
antibiotic resistance
pneumonia
pulmonary microbiome
Microbiology
QR1-502
Ana Elena Pérez-Cobas
Christophe Ginevra
Christophe Rusniok
Sophie Jarraud
Carmen Buchrieser
Persistent Legionnaires’ Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms
description ABSTRACT Despite the importance of pneumonia to public health, little is known about the composition of the lung microbiome during infectious diseases, such as pneumonia, and how it evolves during antibiotic therapy. To study the possible relation of the pulmonary microbiome to the severity and outcome of this respiratory disease, we analyzed the dynamics of the pathogen and the human lung microbiome during persistent infections caused by the bacterium Legionella pneumophila and their evolution during antimicrobial treatment. We collected 10 bronchoalveolar lavage fluid samples from three patients during long-term hospitalization due to pneumonia and performed a unique longitudinal study of the interkingdom microbiome, analyzing the samples for presence of bacteria, archaea, fungi, and protozoa by high-throughput Illumina sequencing of marker genes. The lung microbiome of the patients was characterized by a strong predominance of the pathogen, a low diversity of the bacterial fraction, and an increased presence of opportunistic microorganisms. The fungal fraction was more stable than the bacterial fraction. During long-term treatment, no genomic changes or antibiotic resistance-associated mutations that could explain the persistent infection occurred, according to whole-genome sequencing analyses of the pathogen. After antibiotic treatment, the microbiome did not recover rapidly but was mainly constituted of antibiotic-resistant species and enriched in bacteria, archaea, fungi, or protozoa associated with pathogenicity. The lung microbiome seems to contribute to nonresolving Legionella pneumonia, as it is strongly disturbed during infection and enriched in opportunistic and/or antibiotic-resistant bacteria and microorganisms, including fungi, archaea, and protozoa that are often associated with infections. IMPORTANCE The composition and dynamics of the lung microbiome during pneumonia are not known, although the lung microbiome might influence the severity and outcome of this infectious disease, similar to what was shown for the microbiome at other body sites. Here we report the findings of a comprehensive analysis of the lung microbiome composition of three patients with long-term pneumonia due to L. pneumophila and its evolution during antibiotic treatment. This work adds to our understanding of how the microbiome changes during disease and antibiotic treatment and points to microorganisms and their interactions that might be beneficial. In addition to bacteria and fungi, our analyses included archaea and eukaryotes (protozoa), showing that both are present in the pulmonary microbiota and that they might also play a role in the response to the microbiome disturbance.
format article
author Ana Elena Pérez-Cobas
Christophe Ginevra
Christophe Rusniok
Sophie Jarraud
Carmen Buchrieser
author_facet Ana Elena Pérez-Cobas
Christophe Ginevra
Christophe Rusniok
Sophie Jarraud
Carmen Buchrieser
author_sort Ana Elena Pérez-Cobas
title Persistent Legionnaires’ Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms
title_short Persistent Legionnaires’ Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms
title_full Persistent Legionnaires’ Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms
title_fullStr Persistent Legionnaires’ Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms
title_full_unstemmed Persistent Legionnaires’ Disease and Associated Antibiotic Treatment Engender a Highly Disturbed Pulmonary Microbiome Enriched in Opportunistic Microorganisms
title_sort persistent legionnaires’ disease and associated antibiotic treatment engender a highly disturbed pulmonary microbiome enriched in opportunistic microorganisms
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/30bfe028c1d3403082067cc267659c3d
work_keys_str_mv AT anaelenaperezcobas persistentlegionnairesdiseaseandassociatedantibiotictreatmentengenderahighlydisturbedpulmonarymicrobiomeenrichedinopportunisticmicroorganisms
AT christopheginevra persistentlegionnairesdiseaseandassociatedantibiotictreatmentengenderahighlydisturbedpulmonarymicrobiomeenrichedinopportunisticmicroorganisms
AT christopherusniok persistentlegionnairesdiseaseandassociatedantibiotictreatmentengenderahighlydisturbedpulmonarymicrobiomeenrichedinopportunisticmicroorganisms
AT sophiejarraud persistentlegionnairesdiseaseandassociatedantibiotictreatmentengenderahighlydisturbedpulmonarymicrobiomeenrichedinopportunisticmicroorganisms
AT carmenbuchrieser persistentlegionnairesdiseaseandassociatedantibiotictreatmentengenderahighlydisturbedpulmonarymicrobiomeenrichedinopportunisticmicroorganisms
_version_ 1718427077972066304